Veradermics, Inc SEC filings MANE
Veradermics, Inc has 97 filings in SEC EDGAR's recent list, going back to Oct 9, 2020. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 13, 2026 | — |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 21, 2026 | — |
| 4 | Insider transaction | Aug 21, 2026 | Aug 19, 2026 |
| 3 | Initial insider ownership | Aug 20, 2026 | Aug 10, 2026 |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 18, 2026 | Aug 17, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 14, 2026 | — |
| 144/A | Filing | Aug 14, 2026 | — |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 6, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 7, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 5, 2026 | — |
| 4 | Insider transaction | May 5, 2026 | May 1, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 5, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | May 5, 2026 | — |
| 3 | Initial insider ownership | May 5, 2026 | May 1, 2026 |
| 4/A | Form 4/a | Feb 27, 2026 | Feb 3, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 11, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Feb 11, 2026 | — |
| 4 | Insider transaction | Feb 9, 2026 | Feb 4, 2026 |
| 3 | Initial insider ownership | Feb 9, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 4 | Insider transaction | Feb 5, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
| 3 | Initial insider ownership | Feb 3, 2026 | Feb 3, 2026 |
Showing 55 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MANE (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1827635
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.